Sumary of Ontario science table recommends limiting use of COVID drug due to supply shortage:
- TORONTO — An expert group is recommending that Ontario clinicians ration doses of a drug used to treat COVID-19 patients in light of shortages..
- The group of scientists advising Ontario on the pandemic published revised clinical guidelines this week reflecting the shortage of tocilizumab..
- The COVID-19 science advisory table says the drug is recommended for critically and moderately ill COVID-19 patients within 14 days of hospital admission..
- Dr. Peter Juni of the science table says the change is unlikely to impact patients’ treatment but it was recommended so the maximum number of people can benefit…